Pharmacological Characterization of a Novel Complement C3 Inhibitor Antibody Fragment

Study limitation reported by the research below: “Study design label 'Preclinical In Vitro / Ex Vivo Study' is a best-fit descriptor; no standard canonical label fully captures this mixed laboratory methodology.”